{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:38:11Z","timestamp":1793151491533,"version":"4.5.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100016580","name":"Kennedy Trust for Rheumatology Research","doi-asserted-by":"publisher","award":["KENN 21 22 09"],"award-info":[{"award-number":["KENN 21 22 09"]}],"id":[{"id":"10.13039\/100016580","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016580","name":"Kennedy Trust for Rheumatology Research","doi-asserted-by":"publisher","award":["KENN 21 22 09"],"award-info":[{"award-number":["KENN 21 22 09"]}],"id":[{"id":"10.13039\/100016580","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lister Institute for Preventive Medicine Research Prize"},{"DOI":"10.13039\/501100014034","name":"FOREUM","doi-asserted-by":"crossref","award":["094"],"award-info":[{"award-number":["094"]}],"id":[{"id":"10.13039\/501100014034","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-026-03786-x","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T06:46:11Z","timestamp":1774248371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The gut-joint axis in juvenile idiopathic arthritis"],"prefix":"10.1186","volume":"28","author":[{"given":"Diana E.","family":"Matei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Rosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"3786_CR1","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1093\/rheumatology\/keab714","volume":"61","author":"R Costello","year":"2022","unstructured":"Costello R, McDonagh J, Hyrich KL, Humphreys JH. Incidence and prevalence of juvenile idiopathic arthritis in the United Kingdom, 2000\u20132018: results from the Clinical Practice Research Datalink. Rheumatology (Oxford). 2022;61:2548\u201354.","journal-title":"Rheumatology (Oxford)"},{"key":"3786_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jbspin.2013.09.003","volume":"81","author":"S Thierry","year":"2014","unstructured":"Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 2014;81:112\u20137.","journal-title":"Joint Bone Spine"},{"key":"3786_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-021-00332-8","volume":"8","author":"A Martini","year":"2022","unstructured":"Martini A, et al. Juvenile idiopathic arthritis. Nat Rev Dis Primers. 2022;8:5.","journal-title":"Nat Rev Dis Primers"},{"key":"3786_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12969-024-01037-4","volume":"23","author":"AL Solebo","year":"2025","unstructured":"Solebo AL, Foeldvari I. Reducing the risk of visual disability for children with juvenile idiopathic arthritis uveitis through disease surveillance: past and future challenges. Pediatr Rheumatol Online J. 2025;23:4.","journal-title":"Pediatr Rheumatol Online J"},{"key":"3786_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1136\/ard-2022-222553","volume":"82","author":"LR Wedderburn","year":"2023","unstructured":"Wedderburn LR, et al. Towards molecular-pathology informed clinical trials in childhood arthritis to achieve precision medicine in juvenile idiopathic arthritis. Ann Rheum Dis. 2023;82:449\u201356.","journal-title":"Ann Rheum Dis"},{"key":"3786_CR6","doi-asserted-by":"publisher","first-page":"101496","DOI":"10.1016\/j.berh.2020.101496","volume":"33","author":"S Majumder","year":"2019","unstructured":"Majumder S, Aggarwal A. Juvenile idiopathic arthritis and the gut microbiome: Where are we now? Best Pract Res Clin Rheumatol. 2019;33:101496.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3786_CR7","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"3786_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.clim.2015.04.018","volume":"159","author":"N Bruck","year":"2015","unstructured":"Bruck N, Schnabel A, Hedrich CM. Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches. Clin Immunol. 2015;159:72\u201383.","journal-title":"Clin Immunol"},{"key":"3786_CR9","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1136\/ard-2024-225853","volume":"83","author":"A De Matteis","year":"2024","unstructured":"De Matteis A, et al. Systemic juvenile idiopathic arthritis and adult-onset Still\u2019s disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR\/PReS recommendations for the diagnosis and management of Still\u2019s disease. Ann Rheum Dis. 2024;83:1748\u201361.","journal-title":"Ann Rheum Dis"},{"key":"3786_CR10","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1002\/art.34429","volume":"64","author":"SD Thompson","year":"2012","unstructured":"Thompson SD, et al. Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13. Arthritis Rheum. 2012;64:2781\u201391.","journal-title":"Arthritis Rheum"},{"key":"3786_CR11","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1002\/art.27516","volume":"62","author":"S Prahalad","year":"2010","unstructured":"Prahalad S, et al. Quantification of the familial contribution to juvenile idiopathic arthritis. Arthritis Rheum. 2010;62:2525\u20139.","journal-title":"Arthritis Rheum"},{"key":"3786_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13075-018-1510-6","volume":"20","author":"ML Stoll","year":"2018","unstructured":"Stoll ML, et al. Age and fecal microbial strain-specific differences in patients with spondyloarthritis. Arthritis Res Ther. 2018;20:14.","journal-title":"Arthritis Res Ther"},{"key":"3786_CR13","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/nm.3680","volume":"20","author":"EC Rosser","year":"2014","unstructured":"Rosser EC, et al. Regulatory B cells are induced by gut microbiota-driven interleukin-1beta and interleukin-6 production. Nat Med. 2014;20:1334\u20139.","journal-title":"Nat Med"},{"key":"3786_CR14","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.immuni.2010.06.001","volume":"32","author":"HJ Wu","year":"2010","unstructured":"Wu HJ, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity. 2010;32:815\u201327.","journal-title":"Immunity"},{"key":"3786_CR15","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cmet.2020.03.003","volume":"31","author":"EC Rosser","year":"2020","unstructured":"Rosser EC, et al. Microbiota-derived metabolites suppress arthritis by amplifying aryl-hydrocarbon receptor activation in regulatory b cells. Cell Metab. 2020;31:837\u2013e851810.","journal-title":"Cell Metab"},{"key":"3786_CR16","doi-asserted-by":"publisher","first-page":"15613","DOI":"10.1038\/s41598-017-15802-x","volume":"7","author":"R Rogier","year":"2017","unstructured":"Rogier R, et al. Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis. Sci Rep. 2017;7:15613.","journal-title":"Sci Rep"},{"key":"3786_CR17","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/art.40490","volume":"70","author":"WK Jubair","year":"2018","unstructured":"Jubair WK, et al. Modulation of inflammatory arthritis in mice by gut microbiota through mucosal inflammation and autoantibody generation. Arthritis Rheumatol. 2018;70:1220\u201333.","journal-title":"Arthritis Rheumatol"},{"key":"3786_CR18","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/nm.3914","volume":"21","author":"X Zhang","year":"2015","unstructured":"Zhang X, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21:895\u2013905.","journal-title":"Nat Med"},{"key":"3786_CR19","doi-asserted-by":"publisher","first-page":"763507","DOI":"10.3389\/fcimb.2021.763507","volume":"11","author":"D Yu","year":"2021","unstructured":"Yu D, et al. The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis. Front Cell Infect Microbiol. 2021;11:763507.","journal-title":"Front Cell Infect Microbiol"},{"key":"3786_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.joca.2017.02.484","volume":"25","author":"XL Wu","year":"2017","unstructured":"Wu XL, Xiao J, Lu L, Zhang A. Alterations of Gut Microbiome in Rheumatoid Arthritis. Osteoarthr Cartil. 2017;25:287\u20138.","journal-title":"Osteoarthr Cartil"},{"key":"3786_CR21","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/annrheumdis-2018-214514","volume":"78","author":"D Alpizar-Rodriguez","year":"2019","unstructured":"Alpizar-Rodriguez D, et al. Prevotella copri in individuals at risk for rheumatoid arthritis. Ann Rheum Dis. 2019;78:590\u20133.","journal-title":"Ann Rheum Dis"},{"key":"3786_CR22","doi-asserted-by":"publisher","first-page":"e01202","DOI":"10.7554\/eLife.01202","volume":"2","author":"JU Scher","year":"2013","unstructured":"Scher JU, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife. 2013;2:e01202.","journal-title":"Elife"},{"key":"3786_CR23","doi-asserted-by":"publisher","first-page":"eabn4722","DOI":"10.1126\/scitranslmed.abn4722","volume":"15","author":"KN Thompson","year":"2023","unstructured":"Thompson KN, et al. Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypes. Sci Transl Med. 2023;15:eabn4722.","journal-title":"Sci Transl Med"},{"key":"3786_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13073-016-0299-7","volume":"8","author":"J Chen","year":"2016","unstructured":"Chen J, et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. 2016;8:43.","journal-title":"Genome Med"},{"key":"3786_CR25","doi-asserted-by":"publisher","first-page":"1092118","DOI":"10.3389\/fcimb.2023.1092118","volume":"13","author":"MDS Romero-Figueroa","year":"2023","unstructured":"Romero-Figueroa MDS, Ramirez-Duran N, Montiel-Jarquin AJ, Horta-Baas G. Gut-joint axis: Gut dysbiosis can contribute to the onset of rheumatoid arthritis via multiple pathways. Front Cell Infect Microbiol. 2023;13:1092118.","journal-title":"Front Cell Infect Microbiol"},{"key":"3786_CR26","doi-asserted-by":"publisher","first-page":"1007610","DOI":"10.3389\/fimmu.2022.1007610","volume":"13","author":"X Xu","year":"2022","unstructured":"Xu X, et al. The bridge of the gut-joint axis: Gut microbial metabolites in rheumatoid arthritis. Front Immunol. 2022;13:1007610.","journal-title":"Front Immunol"},{"key":"3786_CR27","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1002\/art.39785","volume":"68","author":"EV Marietta","year":"2016","unstructured":"Marietta EV, et al. Suppression of Inflammatory Arthritis by Human Gut-Derived Prevotella histicola in Humanized Mice. Arthritis Rheumatol. 2016;68:2878\u201388.","journal-title":"Arthritis Rheumatol"},{"key":"3786_CR28","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41590-025-02125-7","volume":"26","author":"T Fan","year":"2025","unstructured":"Fan T, et al. Aberrant T follicular helper cells generated by T(H)17 cell plasticity in the gut promote extraintestinal autoimmunity. Nat Immunol. 2025;26:790\u2013804.","journal-title":"Nat Immunol"},{"key":"3786_CR29","doi-asserted-by":"crossref","unstructured":"Matei DE et al. Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease. 2021;2:864\u201383. e869. e869 .","DOI":"10.1016\/j.medj.2021.04.013"},{"key":"3786_CR30","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/s41467-020-15831-7","volume":"11","author":"N Tajik","year":"2020","unstructured":"Tajik N, et al. Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis. Nat Commun. 2020;11:1995.","journal-title":"Nat Commun"},{"key":"3786_CR31","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.2174\/0929867328666210104110053","volume":"28","author":"J Troisi","year":"2021","unstructured":"Troisi J, et al. The Therapeutic use of the Zonulin Inhibitor AT-1001 (Larazotide) for a Variety of Acute and Chronic Inflammatory Diseases. Curr Med Chem. 2021;28:5788\u2013807.","journal-title":"Curr Med Chem"},{"key":"3786_CR32","doi-asserted-by":"publisher","first-page":"eabm1511","DOI":"10.1126\/sciadv.abm1511","volume":"8","author":"J He","year":"2022","unstructured":"He J, et al. Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis. Sci Adv. 2022;8:eabm1511.","journal-title":"Sci Adv"},{"key":"3786_CR33","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1093\/rheumatology\/keaa125","volume":"59","author":"SH Chu","year":"2020","unstructured":"Chu SH, et al. Circulating plasma metabolites and risk of rheumatoid arthritis in the Nurses\u2019 Health Study. Rheumatology (Oxford). 2020;59:3369\u201379.","journal-title":"Rheumatology (Oxford)"},{"key":"3786_CR34","doi-asserted-by":"crossref","unstructured":"Seymour BJ et al. Microbiota-dependent indole production stimulates the development of collagen-induced arthritis in mice. J Clin Invest. 2023;134(4):e167671.","DOI":"10.1172\/JCI167671"},{"key":"3786_CR35","doi-asserted-by":"publisher","first-page":"6482","DOI":"10.4049\/jimmunol.151.11.6482","volume":"151","author":"AI Lazarovits","year":"1993","unstructured":"Lazarovits AI, Karsh J. Differential expression in rheumatoid synovium and synovial fluid of alpha 4 beta 7 integrin. A novel receptor for fibronectin and vascular cell adhesion molecule-1. J Immunol. 1993;151:6482\u20139.","journal-title":"J Immunol"},{"key":"3786_CR36","doi-asserted-by":"publisher","first-page":"R161","DOI":"10.1186\/ar3120","volume":"12","author":"C Schmutz","year":"2010","unstructured":"Schmutz C, et al. Monocytes\/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation. Arthritis Res Ther. 2010;12:R161.","journal-title":"Arthritis Res Ther"},{"key":"3786_CR37","doi-asserted-by":"publisher","first-page":"e37803","DOI":"10.1097\/MD.0000000000037803","volume":"103","author":"G Lina","year":"2024","unstructured":"Lina G, et al. CCR9\u2009+\u2009CD4+ T cells are associated with disease activity in patients with rheumatoid arthritis. Med (Baltim). 2024;103:e37803.","journal-title":"Med (Baltim)"},{"key":"3786_CR38","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s13075-014-0445-9","volume":"16","author":"W Yokoyama","year":"2014","unstructured":"Yokoyama W, et al. Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice. Arthritis Res Ther. 2014;16:445.","journal-title":"Arthritis Res Ther"},{"key":"3786_CR39","doi-asserted-by":"publisher","first-page":"eadi0672","DOI":"10.1126\/sciimmunol.adi0672","volume":"9","author":"S Galvan-Pena","year":"2024","unstructured":"Galvan-Pena S, Zhu Y, Hanna BS, Mathis D, Benoist C. A dynamic atlas of immunocyte migration from the gut. Sci Immunol. 2024;9:eadi0672.","journal-title":"Sci Immunol"},{"key":"3786_CR40","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3389\/fmicb.2016.01703","volume":"7","author":"M Di Paola","year":"2016","unstructured":"Di Paola M, et al. Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status. Front Microbiol. 2016;7:1703.","journal-title":"Front Microbiol"},{"key":"3786_CR41","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s13075-014-0486-0","volume":"16","author":"ML Stoll","year":"2014","unstructured":"Stoll ML, et al. Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Res Ther. 2014;16:486.","journal-title":"Arthritis Res Ther"},{"key":"3786_CR42","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.12998\/wjcc.v7.i18.2734","volume":"7","author":"YQ Dong","year":"2019","unstructured":"Dong YQ, et al. Characterization of microbiota in systemic-onset juvenile idiopathic arthritis with different disease severities. World J Clin Cases. 2019;7:2734\u201345.","journal-title":"World J Clin Cases"},{"key":"3786_CR43","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/art.40827","volume":"71","author":"EHP van Dijkhuizen","year":"2019","unstructured":"van Dijkhuizen EHP, et al. Microbiome Analytics of the Gut Microbiota in Patients With Juvenile Idiopathic Arthritis: A Longitudinal Observational Cohort Study. Arthritis Rheumatol. 2019;71:1000\u201310.","journal-title":"Arthritis Rheumatol"},{"key":"3786_CR44","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12864-020-6703-0","volume":"21","author":"X Qian","year":"2020","unstructured":"Qian X, et al. Gut microbiota in children with juvenile idiopathic arthritis: characteristics, biomarker identification, and usefulness in clinical prediction. BMC Genomics. 2020;21:286.","journal-title":"BMC Genomics"},{"key":"3786_CR45","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.3899\/jrheum.200551","volume":"48","author":"A Oman","year":"2021","unstructured":"Oman A, Dicksved J, Engstrand L, Berntson L. Fecal Microbiota in Untreated Children With Juvenile Idiopathic Arthritis: A Comparison With Healthy Children and Healthy Siblings. J Rheumatol. 2021;48:1589\u201395.","journal-title":"J Rheumatol"},{"key":"3786_CR46","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10096-015-2548-x","volume":"35","author":"MV Tejesvi","year":"2016","unstructured":"Tejesvi MV, et al. Faecal microbiome in new-onset juvenile idiopathic arthritis. Eur J Clin Microbiol Infect Dis. 2016;35:363\u201370.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3786_CR47","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3899\/jrheum.161589","volume":"44","author":"L Fotis","year":"2017","unstructured":"Fotis L, et al. Serologic Evidence of Gut-driven Systemic Inflammation in Juvenile Idiopathic Arthritis. J Rheumatol. 2017;44:1624\u201331.","journal-title":"J Rheumatol"},{"key":"3786_CR48","first-page":"773","volume":"18","author":"P Picco","year":"2000","unstructured":"Picco P, et al. Increased gut permeability in juvenile chronic arthritides. A multivariate analysis of the diagnostic parameters. Clin Exp Rheumatol. 2000;18:773\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"3786_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fimmu.2017.00103","volume":"8","author":"CL Duurland","year":"2017","unstructured":"Duurland CL, Brown CC, O\u2019Shaughnessy RF, Wedderburn LR. CD161(+) Tconv and CD161(+) Treg Share a Transcriptional and Functional Phenotype despite Limited Overlap in TCRbeta Repertoire. Front Immunol. 2017;8:103.","journal-title":"Front Immunol"},{"key":"3786_CR50","first-page":"9","volume":"72","author":"MF van den Broek","year":"1988","unstructured":"van den Broek MF, van den Berg WB, Arntz OJ, van de Putte LB. Reaction of bacterium-primed murine T cells to cartilage components: a clue for the pathogenesis of arthritis? Clin Exp Immunol. 1988;72:9\u201314.","journal-title":"Clin Exp Immunol"},{"key":"3786_CR51","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/art.1780310825","volume":"31","author":"MF Van den Broek","year":"1988","unstructured":"Van den Broek MF, Van de Putte LB, Van den Berg WB. Crohn\u2019s disease associated with arthritis: a possible role for cross-reactivity between gut bacteria and cartilage in the pathogenesis of arthritis. Arthritis Rheum. 1988;31:1077\u20139.","journal-title":"Arthritis Rheum"},{"key":"3786_CR52","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/MPG.0000000000003656","volume":"76","author":"IJ Broekaert","year":"2023","unstructured":"Broekaert IJ, et al. Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics. J Pediatr Gastroenterol Nutr. 2023;76:174\u201382.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3786_CR53","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1093\/rheumatology\/keab678","volume":"61","author":"JW van Straalen","year":"2022","unstructured":"van Straalen JW, et al. Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use. Rheumatology (Oxford). 2022;61:2104\u201312.","journal-title":"Rheumatology (Oxford)"},{"key":"3786_CR54","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3899\/jrheum.100809","volume":"38","author":"TD van Dijken","year":"2011","unstructured":"van Dijken TD, et al. Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with etanercept. J Rheumatol. 2011;38:1441\u20136.","journal-title":"J Rheumatol"},{"key":"3786_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3748\/wjg.v20.i1.45","volume":"20","author":"S Cardile","year":"2014","unstructured":"Cardile S, Romano C. Current issues in pediatric inflammatory bowel disease-associated arthropathies. World J Gastroenterol. 2014;20:45\u201352.","journal-title":"World J Gastroenterol"},{"key":"3786_CR56","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/BF01320313","volume":"31","author":"MH Passo","year":"1986","unstructured":"Passo MH, Fitzgerald JF, Brandt KD. Arthritis associated with inflammatory bowel disease in children. Relationship of joint disease to activity and severity of bowel lesion. Dig Dis Sci. 1986;31:492\u20137.","journal-title":"Dig Dis Sci"},{"key":"3786_CR57","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0889-8553(01)00019-X","volume":"31","author":"CG Su","year":"2002","unstructured":"Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:307\u201327.","journal-title":"Gastroenterol Clin North Am"},{"key":"3786_CR58","first-page":"22","volume":"20","author":"A Stawarski","year":"2006","unstructured":"Stawarski A, Iwanczak B, Krzesiek E, Iwanczak F. [Intestinal complications and extraintestinal manifestations in children with inflammatory bowel disease]. Pol Merkur Lekarski. 2006;20:22\u20135.","journal-title":"Pol Merkur Lekarski"},{"key":"3786_CR59","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1093\/rheumatology\/keq136","volume":"49","author":"A Dallocchio","year":"2010","unstructured":"Dallocchio A, et al. Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study. Rheumatology (Oxford). 2010;49:1694\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"3786_CR60","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-020-0454-9","volume":"16","author":"E Gracey","year":"2020","unstructured":"Gracey E, et al. Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis. Nat Rev Rheumatol. 2020;16:415\u201333.","journal-title":"Nat Rev Rheumatol"},{"key":"3786_CR61","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1053\/gast.1996.v110.pm8964393","volume":"110","author":"M De Vos","year":"1996","unstructured":"De Vos M, Mielants H, Cuvelier C, Elewaut A, Veys E. Long-term evolution of gut inflammation in patients with spondyloarthropathy. Gastroenterology. 1996;110:1696\u2013703.","journal-title":"Gastroenterology"},{"key":"3786_CR62","doi-asserted-by":"publisher","first-page":"105923","DOI":"10.1016\/j.jbspin.2025.105923","volume":"92","author":"D Mauro","year":"2025","unstructured":"Mauro D, et al. The role of the gut and intestinal dysbiosis in the pathogenesis of spondyloarthritis. Joint Bone Spine. 2025;92:105923.","journal-title":"Joint Bone Spine"},{"key":"3786_CR63","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrg3502","volume":"14","author":"M Parkes","year":"2013","unstructured":"Parkes M, Cortes A, van Heel DA, Brown MA. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat Rev Genet. 2013;14:661\u201373.","journal-title":"Nat Rev Genet"},{"key":"3786_CR64","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/art.38963","volume":"67","author":"RB Schittenhelm","year":"2015","unstructured":"Schittenhelm RB, Sian TC, Wilmann PG, Dudek NL, Purcell AW. Revisiting the arthritogenic peptide theory: quantitative not qualitative changes in the peptide repertoire of HLA-B27 allotypes. Arthritis Rheumatol. 2015;67:702\u201313.","journal-title":"Arthritis Rheumatol"},{"key":"3786_CR65","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00281-021-00845-0","volume":"43","author":"Z Qaiyum","year":"2021","unstructured":"Qaiyum Z, Lim M, Inman RD. The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights. Semin Immunopathol. 2021;43:173\u201392.","journal-title":"Semin Immunopathol"},{"key":"3786_CR66","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/0140-6736(93)91760-J","volume":"342","author":"E Hermann","year":"1993","unstructured":"Hermann E, Yu DT, Meyer zum Buschenfelde KH, Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet. 1993;342:646\u201350.","journal-title":"Lancet"},{"key":"3786_CR67","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1053\/gast.2000.20173","volume":"119","author":"E May","year":"2000","unstructured":"May E, et al. Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy. Gastroenterology. 2000;119:1745\u201355.","journal-title":"Gastroenterology"},{"key":"3786_CR68","first-page":"1932","volume":"25","author":"D Elewaut","year":"1998","unstructured":"Elewaut D, et al. Enrichment of T cells carrying beta7 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis. J Rheumatol. 1998;25:1932\u20137.","journal-title":"J Rheumatol"},{"key":"3786_CR69","doi-asserted-by":"crossref","unstructured":"Yau E, et al. Effect of Integrin Blockade on Experimental Spondyloarthritis. Biomolecules. 2024;14(11):1386.","DOI":"10.3390\/biom14111386"},{"key":"3786_CR70","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/rheumatology\/kel056","volume":"45","author":"N Saxena","year":"2006","unstructured":"Saxena N, Misra R, Aggarwal A. Is the enthesitis-related arthritis subtype of juvenile idiopathic arthritis a form of chronic reactive arthritis? Rheumatology (Oxford). 2006;45:1129\u201332.","journal-title":"Rheumatology (Oxford)"},{"key":"3786_CR71","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/ard-2023-224014","volume":"83","author":"D Moulin","year":"2024","unstructured":"Moulin D, et al. Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis. Ann Rheum Dis. 2024;83:312\u201323.","journal-title":"Ann Rheum Dis"},{"key":"3786_CR72","doi-asserted-by":"publisher","first-page":"104654","DOI":"10.1016\/j.ebiom.2023.104654","volume":"93","author":"E Kindgren","year":"2023","unstructured":"Kindgren E, Ahrens AP, Triplett EW, Ludvigsson J. Infant gut microbiota and environment associate with juvenile idiopathic arthritis many years prior to disease onset, especially in genetically vulnerable children. EBioMedicine. 2023;93:104654.","journal-title":"EBioMedicine"},{"key":"3786_CR73","doi-asserted-by":"crossref","unstructured":"Belzer C et al. Microbial Metabolic Networks at the Mucus Layer Lead to Diet-Independent Butyrate and Vitamin B(12) Production by Intestinal Symbionts. mBio 2017;8(5):e00770\u201317.","DOI":"10.1128\/mBio.00770-17"},{"key":"3786_CR74","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1136\/gutjnl-2023-330291","volume":"72","author":"X Kang","year":"2023","unstructured":"Kang X, et al. Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8(+) T cells. Gut. 2023;72:2112\u201322.","journal-title":"Gut"},{"key":"3786_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2019.1613124","volume":"11","author":"C Lordan","year":"2020","unstructured":"Lordan C, Thapa D, Ross RP, Cotter PD. Potential for enriching next-generation health-promoting gut bacteria through prebiotics and other dietary components. Gut Microbes. 2020;11:1\u201320.","journal-title":"Gut Microbes"},{"key":"3786_CR76","doi-asserted-by":"crossref","unstructured":"Hestetun S, Andersen S, Sanner H, Stordal K. Antibiotic exposure in prenatal and early life and risk of juvenile idiopathic arthritis: a nationwide register-based cohort study. RMD Open. 2023;9(3):e003333.","DOI":"10.1136\/rmdopen-2023-003333"},{"key":"3786_CR77","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/acr.22806","volume":"68","author":"S Shenoi","year":"2016","unstructured":"Shenoi S, Shaffer ML, Wallace CA. Environmental Risk Factors and Early-Life Exposures in Juvenile Idiopathic Arthritis: A Case-Control Study. Arthritis Care Res (Hoboken). 2016;68:1186\u201394.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3786_CR78","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s12519-019-00278-8","volume":"15","author":"C McLean","year":"2019","unstructured":"McLean C, Jun S, Kozyrskyj A. Impact of maternal smoking on the infant gut microbiota and its association with child overweight: a scoping review. World J Pediatr. 2019;15:341\u20139.","journal-title":"World J Pediatr"},{"key":"3786_CR79","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41522-021-00265-w","volume":"8","author":"A Amir","year":"2022","unstructured":"Amir A, et al. Gut microbiome development in early childhood is affected by day care attendance. NPJ Biofilms Microbiomes. 2022;8:2.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"3786_CR80","doi-asserted-by":"publisher","first-page":"629740","DOI":"10.3389\/fnut.2021.629740","volume":"8","author":"G Boudry","year":"2021","unstructured":"Boudry G, et al. The Relationship Between Breast Milk Components and the Infant Gut Microbiota. Front Nutr. 2021;8:629740.","journal-title":"Front Nutr"},{"key":"3786_CR81","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3899\/jrheum.2023-1203","volume":"51","author":"KH Baggett","year":"2024","unstructured":"Baggett KH, Brandon TG, Xiao R, Weiss PF. Association of Infant Breastfeeding and Juvenile Spondyloarthritis: A Case-Control Study. J Rheumatol. 2024;51:708\u201314.","journal-title":"J Rheumatol"},{"key":"3786_CR82","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/1756-185X.14431","volume":"25","author":"O Koker","year":"2022","unstructured":"Koker O, et al. An overview of the relationship between juvenile idiopathic arthritis and potential environmental risk factors: Do early childhood habits or habitat play a role in the affair? Int J Rheum Dis. 2022;25:1376\u201385.","journal-title":"Int J Rheum Dis"},{"key":"3786_CR83","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1007\/s00431-021-03987-3","volume":"180","author":"L Raisanen","year":"2021","unstructured":"Raisanen L, Viljakainen H, Sarkkola C, Kolho KL. Perinatal risk factors for pediatric onset type 1 diabetes, autoimmune thyroiditis, juvenile idiopathic arthritis, and inflammatory bowel diseases. Eur J Pediatr. 2021;180:2115\u201323.","journal-title":"Eur J Pediatr"},{"key":"3786_CR84","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41584-021-00585-3","volume":"17","author":"MM Zaiss","year":"2021","unstructured":"Zaiss MM, Wu J, Mauro HJ, Schett D, G., Ciccia F. The gut-joint axis in rheumatoid arthritis. Nat Rev Rheumatol. 2021;17:224\u201337.","journal-title":"Nat Rev Rheumatol"},{"key":"3786_CR85","doi-asserted-by":"publisher","first-page":"127973","DOI":"10.1016\/j.micres.2024.127973","volume":"290","author":"J Li","year":"2025","unstructured":"Li J, et al. Role of gut microbiota in rheumatoid arthritis: Potential cellular mechanisms regulated by prebiotic, probiotic, and pharmacological interventions. Microbiol Res. 2025;290:127973.","journal-title":"Microbiol Res"},{"key":"3786_CR86","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/cei.12818","volume":"185","author":"A Shukla","year":"2016","unstructured":"Shukla A, Gaur P, Aggarwal A. Effect of probiotics on clinical and immune parameters in enthesitis-related arthritis category of juvenile idiopathic arthritis. Clin Exp Immunol. 2016;185:301\u20138.","journal-title":"Clin Exp Immunol"},{"key":"3786_CR87","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1365-2036.2008.03796.x","volume":"28","author":"ST Leach","year":"2008","unstructured":"Leach ST, Mitchell HM, Eng WR, Zhang L, Day AS. Sustained modulation of intestinal bacteria by exclusive enteral nutrition used to treat children with Crohn\u2019s disease. Aliment Pharmacol Ther. 2008;28:724\u201333.","journal-title":"Aliment Pharmacol Ther"},{"key":"3786_CR88","first-page":"941","volume":"34","author":"L Berntson","year":"2016","unstructured":"Berntson L, Hedlund-Treutiger I, Alving K. Anti-inflammatory effect of exclusive enteral nutrition in patients with juvenile idiopathic arthritis. Clin Exp Rheumatol. 2016;34:941\u20135.","journal-title":"Clin Exp Rheumatol"},{"key":"3786_CR89","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12969-021-00577-3","volume":"19","author":"L Berntson","year":"2021","unstructured":"Berntson L. A pilot study of possible anti-inflammatory effects of the specific carbohydrate diet in children with juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2021;19:88.","journal-title":"Pediatr Rheumatol Online J"},{"key":"3786_CR90","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0049-0172(90)90022-8","volume":"20","author":"MC Bacon","year":"1990","unstructured":"Bacon MC, et al. Nutritional status and growth in juvenile rheumatoid arthritis. Semin Arthritis Rheum. 1990;20:97\u2013106.","journal-title":"Semin Arthritis Rheum"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03786-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03786-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03786-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:02:17Z","timestamp":1777528937000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03786-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3786"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03786-x","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}